SCHEMBL3628501

SCHEMBL3628501

Cc1cccc(C)c1Oc1cccc2c1CCC2=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 2/20 0.45
BRAF P15056 2/20 0.44
GAA P10253 1/20 0.42
ABCB1 P08183 2/20 0.41
TYMS P04818 1/20 0.40
HTR1A P08908 2/20 0.39
SLC6A4 P31645 2/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
TSHR P16473 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
PARP1 P09874 1/20 0.38
PARP10 Q53GL7 1/20 0.38
PARP11 Q9NR21 1/20 0.38
BRD4 O60885 3/20 0.38
CYP19A1 P11511 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29495011 0.79 PARP1 (0.56) ALDH1A1HPGDKDM4EGAATYMS
SCHEMBL163780 0.79 PARP1 (0.56) ALDH1A1HPGDKDM4EGAATYMS
SCHEMBL29506042 0.78 KDM4E (0.61) ALDH1A1HPGDKDM4EBRAFGAA
SCHEMBL165220 0.78 KDM4E (0.61) ALDH1A1HPGDKDM4EBRAFGAA
SCHEMBL3628910 0.77 BRD4 (0.46) ALDH1A1HPGDKDM4EBRAFGAA
SCHEMBL18500523 0.74 ABCB1 (0.46) ALDH1A1HPGDKDM4EBRAFGAA
SCHEMBL28393186 0.74 TYMS (0.45) ALDH1A1HPGDKDM4EGAATYMS
SCHEMBL13418124 0.74 ABCB1 (0.46) ALDH1A1HPGDKDM4EBRAFGAA
SCHEMBL3624614 0.74 TYMS (0.47) ALDH1A1HPGDKDM4EGAATYMS
SCHEMBL24510647 0.73 ABCB1 (0.52) ALDH1A1HPGDKDM4EGAAABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-7786165-B2 Aminophenylpropanoic acid derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-31 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269220-A1 Aminophenylpropanoic Acid Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
EP-1726580-A1 AMINOPHENYLPROPANOIC ACID DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269220-A1 Aminophenylpropanoic Acid Derivative GPR119, GPR55, GPR65 ALDH1A1 495/4885HPGD 2123/4885KDM4E 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.